On Nov. 2, the Centers for Medicare & Medicaid Services (CMS) issued its final 2024 outpatient rule, which
finalized several updates it had proposed to the federal Price Transparency Rule for hospitals.
In its comment letter, WHA had recommended CMS to ensure its updates provide truly meaningful information for consumers as opposed to placating third-party organizations that are not interested in helping patients. In the final rule, CMS ended up finalizing proposals to:
CMS also finalized a number of its proposed quality program updates but decided not to go ahead with its proposal to create a new payment for hospitals to create a buffer stock of new medicines. You can find details of these proposals in the final rule here.
On Nov. 2, the Centers for Medicare & Medicaid Services (CMS) issued its final 2024 outpatient rule, which
finalized several updates it had proposed to the federal Price Transparency Rule for hospitals.
In its comment letter, WHA had recommended CMS to ensure its updates provide truly meaningful information for consumers as opposed to placating third-party organizations that are not interested in helping patients. In the final rule, CMS ended up finalizing proposals to:
CMS also finalized a number of its proposed quality program updates but decided not to go ahead with its proposal to create a new payment for hospitals to create a buffer stock of new medicines. You can find details of these proposals in the final rule here.